These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 30470250)
1. miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC. Wang X; Meng Q; Qiao W; Ma R; Ju W; Hu J; Lu H; Cui J; Jin Z; Zhao Y; Wang Y Stem Cell Res Ther; 2018 Nov; 9(1):327. PubMed ID: 30470250 [TBL] [Abstract][Full Text] [Related]
2. MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC. Wang X; Chen X; Meng Q; Jing H; Lu H; Yang Y; Cai L; Zhao Y Sci Rep; 2015 Dec; 5():17618. PubMed ID: 26620926 [TBL] [Abstract][Full Text] [Related]
3. The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis. Huang TT; Ping YH; Wang AM; Ke CC; Fang WL; Huang KH; Lee HC; Chi CW; Yeh TS Oncotarget; 2015 Jul; 6(20):18012-26. PubMed ID: 26041881 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy. Hua L; Zhu G; Wei J Cell Biol Int; 2018 Sep; 42(9):1240-1249. PubMed ID: 29851226 [TBL] [Abstract][Full Text] [Related]
6. miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein. Zhu X; Li D; Yu F; Jia C; Xie J; Ma Y; Fan S; Cai H; Luo Q; Lv Z; Fan L Oncotarget; 2016 Mar; 7(11):13139-52. PubMed ID: 26909612 [TBL] [Abstract][Full Text] [Related]
7. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway. Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061 [TBL] [Abstract][Full Text] [Related]
8. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1. Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120 [TBL] [Abstract][Full Text] [Related]
9. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis. Wang L; Shang X; Feng Q Cancer Biol Ther; 2019; 20(3):261-271. PubMed ID: 30481109 [TBL] [Abstract][Full Text] [Related]
10. MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1. Ma Z; Cai H; Zhang Y; Chang L; Cui Y Biochem Biophys Res Commun; 2017 Aug; 490(2):309-316. PubMed ID: 28619508 [TBL] [Abstract][Full Text] [Related]
11. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway. Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related]
13. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC. Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871 [TBL] [Abstract][Full Text] [Related]
14. MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer. Ke X; Yuan Y; Guo C; Yang Y; Pu Q; Hu X; Tang K; Luo X; Jiang Q; Su X; Liu L; Zhu W; Wei Y Oncotarget; 2017 Feb; 8(7):11356-11371. PubMed ID: 28076327 [TBL] [Abstract][Full Text] [Related]
15. Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14. Yu F; Liu JB; Wu ZJ; Xie WT; Zhong XJ; Hou LK; Wu W; Lu HM; Jiang XH; Jiang JJ; Cao ZY; Cong GJ; Shi MX; Jia CY; Lu GX; Song YC; Chai L; Lv ZW; Wu CY; Ma YS; Fu D Cancer Lett; 2018 Jul; 427():74-84. PubMed ID: 29702194 [TBL] [Abstract][Full Text] [Related]
16. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9. Rao C; Miao X; Zhao G; Zhang C; Shen H; Dong C; Yang M Biomed Pharmacother; 2019 Jun; 114():108662. PubMed ID: 30999114 [TBL] [Abstract][Full Text] [Related]
17. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8. Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821 [TBL] [Abstract][Full Text] [Related]
18. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer. Li QQ; Xie YK; Wu Y; Li LL; Liu Y; Miao XB; Liu QZ; Yao KT; Xiao GH Oncotarget; 2017 Feb; 8(7):12067-12080. PubMed ID: 28076844 [TBL] [Abstract][Full Text] [Related]
19. microRNA-181b suppresses the metastasis of lung cancer cells by targeting sex determining region Y-related high mobility group-box 6 (Sox6). Zhou Y; Zheng X; Chen LJ; Xu B; Jiang JT Pathol Res Pract; 2019 Feb; 215(2):335-342. PubMed ID: 30580904 [TBL] [Abstract][Full Text] [Related]
20. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC. Wang R; Dong HX; Zeng J; Pan J; Jin XY J Cell Physiol; 2018 Sep; 233(9):7447-7456. PubMed ID: 29663359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]